Drug Type Small molecule drug |
Synonyms USP7 inhibitors (Almac Discovery), ALM 701, ALM701 |
Target |
Action inhibitors |
Mechanism USP7 inhibitors(ubiquitin specific peptidase 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epstein-Barr virus associated Neoplasms | Preclinical | United Kingdom | 01 Apr 2026 |





